The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease

dc.authoridcanbaz kabay, sibel/0000-0003-4808-2191
dc.authoridsevim, mehmet/0000-0002-7571-7669
dc.contributor.authorKabay, Sahin
dc.contributor.authorKabay, Sibel Canbaz
dc.contributor.authorCetiner, Mustafa
dc.contributor.authorMestan, Emine
dc.contributor.authorSevim, Mehmet
dc.contributor.authorAyas, Selahattin
dc.contributor.authorOzden, Hilmi
dc.date.accessioned2025-01-27T20:16:43Z
dc.date.available2025-01-27T20:16:43Z
dc.date.issued2016
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractOBJECTIVE To investigate the effect of percutaneous posterior tibial nerve stimulation (PTNS) treatment after 12 weeks on urodynamic and clinical findings in patients with Parkinson's disease (PD) with neurogenic detrusor overactivity. METHODS A total of 47 patients with PD with neurogenic detrusor overactivity were enrolled in the study. Urodynamic studies before and after 12-week PTNS treatment were performed. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), Overactive Bladder Questionnaire (OAB-V8), and Overactive Bladder Questionnaire Short Form (OAB-q SF) have been assessed before and after PTNS treatment. RESULTS The mean first involuntary detrusor contraction volume (1st IDCV) on standard cystometry was 133.2 +/- 48.1 (24-265) mL, whereas it was 237.3 +/- 43.1 (145-390) mL after PTNS. The mean maximum cystometric capacity (MCC) on standard cystometry was 202.2 +/- 36.5 (115-320) mL, whereas it was 292.1 +/- 50.6 (195-395) mL after stimulation. The improvements in the first involuntary detrusor contraction volume and maximum cystometric capacity were statistically significant after stimulation. The mean Pdetmax at first involuntary detrusor contraction, maximal detrusor pressure at maximum cystometric capacity, PdetQmax, Qmax, and post-void residual volume were statistically significant after 12-week stimulation. Mean parametric improvements at 12-week PTNS treatment from baseline included daytime frequency decreased by 5.6 voids daily, urge incontinence decreased by 3.1 episodes daily, urgency episodes decreased by 6.3 episodes daily, nocturia decreased by 2.7 voids, and voided volume improved by a mean of 92.6 mL. The change from baseline on the ICIQ-SF, OABv8, and OAB-q at 12-week PTNS treatment demonstrated statistically significant improvements. CONCLUSION These results have demonstrated that PTNS improves the lower urinary tract symptoms and urodynamic parameters in patients with PD. (C) 2015 Elsevier Inc.
dc.identifier.doi10.1016/j.urology.2015.09.026
dc.identifier.endpage81
dc.identifier.issn0090-4295
dc.identifier.issn1527-9995
dc.identifier.pmid26436213
dc.identifier.scopus2-s2.0-84959282811
dc.identifier.scopusqualityQ2
dc.identifier.startpage76
dc.identifier.urihttps://doi.org/10.1016/j.urology.2015.09.026
dc.identifier.urihttps://hdl.handle.net/20.500.12428/21366
dc.identifier.volume87
dc.identifier.wosWOS:000373463300022
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofUrology
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectBladder
dc.subjectDysfunction
dc.subjectNeuromodulation
dc.subjectIncontinence
dc.subjectMotor
dc.titleThe Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease
dc.typeArticle

Dosyalar